Collegium Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 29 Feb 24 | SellUS$36,580 | Thomas Smith | Individual | 995 | US$36.76 |
Insider Trading Volume
Insider Buying: COLL insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 1,096 | 0.00272% |
| State or Government | 24,290 | 0.0603% |
| Individual Insiders | 450,785 | 1.12% |
| Hedge Funds | 2,758,253 | 6.85% |
| Institutions | 37,052,575 | 92% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,786,993 | US$201.0m | -7.27% | no data | |||
| 2,758,253 | US$95.8m | -13.1% | 3.22% | |||
| 2,630,478 | US$91.4m | -0.03% | 1.6% | |||
| 2,312,786 | US$80.3m | -1.12% | no data | |||
| 2,174,718 | US$75.5m | 68.4% | 0.22% | |||
| 1,570,454 | US$54.6m | -0.56% | 0.03% | |||
| 1,384,598 | US$48.1m | 18.1% | 0.07% | |||
| 1,313,875 | US$45.6m | 1.81% | no data | |||
| 1,217,890 | US$42.3m | -2.57% | 1.05% | |||
| 1,050,000 | US$36.5m | 0% | 1.29% | |||
| 1,039,218 | US$36.1m | 2.92% | 0.01% | |||
| 996,878 | US$34.6m | 2.72% | 0.01% | |||
| 731,266 | US$25.4m | 2.87% | no data | |||
| 723,297 | US$25.1m | -3.34% | 0.02% | |||
| 665,118 | US$23.1m | 0.09% | 0.01% | |||
| 660,622 | US$23.0m | 167% | no data | |||
| 627,512 | US$21.8m | -28.7% | 0.01% | |||
| 562,000 | US$19.5m | 0% | 0.56% | |||
| 444,739 | US$15.5m | 135% | 0.01% | |||
| 443,645 | US$15.4m | -8.14% | 0.01% | |||
| 400,867 | US$13.9m | -0.78% | no data | |||
| 374,115 | US$13.0m | -2.41% | 0.1% | |||
| 361,363 | US$12.6m | 3.19% | 0.5% | |||
| 345,840 | US$12.0m | -18.8% | 0.03% | |||
| 344,532 | US$12.0m | -25% | 0.33% |